For: | Berardis S, Sattwika PD, Najimi M, Sokal EM. Use of mesenchymal stem cells to treat liver fibrosis: Current situation and future prospects. World J Gastroenterol 2015; 21(3): 742-758 [PMID: 25624709 DOI: 10.3748/wjg.v21.i3.742] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v21/i3/742.htm |
Number | Citing Articles |
1 |
Hongyu Zhang, Christopher T. Siegel, Jing Li, Jiejuan Lai, Ling Shuai, Xiangdong Lai, Yujun Zhang, Yan Jiang, Ping Bie, Lianhua Bai. Functional liver tissue engineering by an adult mouse liver-derived neuro-glia antigen 2-expressing stem/progenitor population. Journal of Tissue Engineering and Regenerative Medicine 2018; 12(1): e190 doi: 10.1002/term.2311
|
2 |
Dongkyu Kim, Gun-Sik Cho, Choongseong Han, Dong-Hyuk Park, Hee-Kyung Park, Dong-Hun Woo, Jong-Hoon Kim. Current Understanding of Stem Cell and Secretome Therapies in Liver Diseases. Tissue Engineering and Regenerative Medicine 2017; 14(6): 653 doi: 10.1007/s13770-017-0093-7
|
3 |
Sandra Brückner, Alexander Zipprich, Madlen Hempel, Antje Thonig, Fabian Schwill, Martin Roderfeld, Elke Roeb, Bruno Christ. Improvement of portal venous pressure in cirrhotic rat livers by systemic treatment with adipose tissue–derived mesenchymal stromal cells. Cytotherapy 2017; 19(12): 1462 doi: 10.1016/j.jcyt.2017.09.006
|
4 |
Neveen A. Salem, Hanaa H. Ahmed, Hadeer A. Aglan, Shaimaa A. ElShebiney. Nanofiber-expanded stem cells mitigate liver fibrosis: Experimental study. Tissue and Cell 2016; 48(5): 544 doi: 10.1016/j.tice.2016.06.005
|
5 |
Eiko Saijou, Yutaka Enomoto, Michitaka Matsuda, Cindy Yuet‐Yin Kok, Shizuo Akira, Minoru Tanaka, Atsushi Miyajima. Neutrophils alleviate fibrosis in the CCl4‐induced mouse chronic liver injury model. Hepatology Communications 2018; 2(6): 703 doi: 10.1002/hep4.1178
|
6 |
Nadeem Siddiqui, Simran Asawa, Bhaskar Birru, Ramaraju Baadhe, Sreenivasa Rao. PCL-Based Composite Scaffold Matrices for Tissue Engineering Applications. Molecular Biotechnology 2018; 60(7): 506 doi: 10.1007/s12033-018-0084-5
|
7 |
Danny van der Helm, Marieke C. Barnhoorn, Eveline S. M. de Jonge‐Muller, Ilse Molendijk, Luuk J. A. C. Hawinkels, Minneke J. Coenraad, Bart van Hoek, Hein W. Verspaget. Local but not systemic administration of mesenchymal stromal cells ameliorates fibrogenesis in regenerating livers. Journal of Cellular and Molecular Medicine 2019; 23(9): 6238 doi: 10.1111/jcmm.14508
|
8 |
Mustapha Najimi, Sébastien Michel, Maria M. Binda, Kris Gellynck, Nathalie Belmonte, Giuseppe Mazza, Noelia Gordillo, Yelena Vainilovich, Etienne Sokal. Human Allogeneic Liver-Derived Progenitor Cells Significantly Improve NAFLD Activity Score and Fibrosis in Late-Stage NASH Animal Model. Cells 2022; 11(18): 2854 doi: 10.3390/cells11182854
|
9 |
Danny van der Helm, Arwin Groenewoud, Eveline S. M. de Jonge-Muller, Marieke. C. Barnhoorn, Mark J. A. Schoonderwoerd, Minneke J. Coenraad, Lukas J. A. C. Hawinkels, B. Ewa Snaar-Jagalska, Bart van Hoek, Hein W. Verspaget. Mesenchymal stromal cells prevent progression of liver fibrosis in a novel zebrafish embryo model. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-34351-5
|
10 |
MATTHEW E. KINNEY. Fowler' s Zoo and Wild Animal Medicine Current Therapy, Volume 10. 2023; : 789 doi: 10.1016/B978-0-323-82852-9.00110-6
|
11 |
Andrei Marian Feier, Diana Portan, Doina Ramona Manu, Vassilis Kostopoulos, Athanasios Kotrotsos, Gabriela Strnad, Minodora Dobreanu, Andreea Salcudean, Tiberiu Bataga. Primary MSCs for Personalized Medicine: Ethical Challenges, Isolation and Biocompatibility Evaluation of 3D Electrospun and Printed Scaffolds. Biomedicines 2022; 10(7): 1563 doi: 10.3390/biomedicines10071563
|
12 |
Raphael Gorodetsky, Wilhelm K. Aicher. Allogenic Use of Human Placenta-Derived Stromal Cells as a Highly Active Subtype of Mesenchymal Stromal Cells for Cell-Based Therapies. International Journal of Molecular Sciences 2021; 22(10): 5302 doi: 10.3390/ijms22105302
|
13 |
Lijun Chen, Chunfeng Zhang, Lu Chen, Xiaojun Wang, Bingyu Xiang, Xiaoxing Wu, Yang Guo, Xiaozhou Mou, Li Yuan, Bo Chen, Jinfu Wang, Charlie Xiang. Human Menstrual Blood-Derived Stem Cells Ameliorate Liver Fibrosis in Mice by Targeting Hepatic Stellate Cells via Paracrine Mediators. Stem Cells Translational Medicine 2017; 6(1): 272 doi: 10.5966/sctm.2015-0265
|
14 |
Ping Wang, Francesco Petrella, Luca Nicosia, Massimo Bellomi, Stefania Rizzo, Gary E. Lyons. Molecular Imaging of Stem Cell Transplantation for Liver Diseases: Monitoring, Clinical Translation, and Theranostics. Stem Cells International 2016; 2016(1) doi: 10.1155/2016/4058656
|
15 |
Zhang, MD Yue, Ding, MD Hong, Wu, MD Shengdi, Fan, MD Peili, Li, MD Zheng, Zeng, MD Wenjiao, Wang, MD Wenping. Histological Reference for Shear Wave Elastography in Liver Fibrosis: Collagen Quantification and Scoring System. ADVANCED ULTRASOUND IN DIAGNOSIS AND THERAPY 2019; 3(3): 87 doi: 10.37015/AUDT.2019.190815
|
16 |
A. I. Bozhkov, S. L. Ohiienko, Yu. A. Kuznetsova, A. Yu. Bondar’, V. P. Marchenko, M. S. Gumennaya. Donor Age Affects Behavior and Sensibility of Bone Marrow Cells to Copper Ions in Primary Culture. Advances in Gerontology 2017; 7(4): 336 doi: 10.1134/S2079057017040026
|
17 |
Sudarma Bogahawaththa, Suranga P. Kodithuwakku, Kavindra K. Wijesundera, Eranga H. Siriweera, Lalith Jayasinghe, Waruna L. Dissanayaka, Jayanthe Rajapakse, Chandana B. Herath, Tadayuki Tsujita, Missaka P. B. Wijayagunawardane. Anti-Fibrotic and Anti-Angiogenic Activities of Osbeckia octandra Leaf Extracts in Thioacetamide-Induced Experimental Liver Cirrhosis. Molecules 2021; 26(16): 4836 doi: 10.3390/molecules26164836
|
18 |
Qi Liu, Chengqian Lv, Qianqian Huang, Lei Zhao, Xiaoli Sun, Dandan Ning, Jingyang Liu, Yanan Jiang, Shizhu Jin. ECM1 modified HF-MSCs targeting HSC attenuate liver cirrhosis by inhibiting the TGF-β/Smad signaling pathway. Cell Death Discovery 2022; 8(1) doi: 10.1038/s41420-022-00846-4
|
19 |
Shoko Momiyama, Yasushi Nunokawa, Nobuko Nunokawa, Ikeda Hirokazu, Ayumi Kawanishi, Keita Iyori. A Case of Canine Necrolytic Migratory Erythema Treated with Adipose-derived Stem Cells Therapy. The Japanese Journal of Veterinary Dermatology 2018; 24(3): 141 doi: 10.2736/jjvd.24.141
|
20 |
Alicia Fernández-Colino, Laura Iop, Mónica S. Ventura Ferreira, Petra Mela. Fibrosis in tissue engineering and regenerative medicine: treat or trigger?. Advanced Drug Delivery Reviews 2019; 146: 17 doi: 10.1016/j.addr.2019.07.007
|
21 |
Junko Haga, Shin Enosawa, Eiji Kobayashi. Cell Therapy for Liver Disease Using Bioimaging Rats. Cell Medicine 2017; 9(1-2): 3 doi: 10.3727/215517916X693104
|
22 |
Chun-Ye Zhang, Shuai Liu, Ming Yang. Treatment of liver fibrosis: Past, current, and future. World Journal of Hepatology 2023; 15(6): 755-774 doi: 10.4254/wjh.v15.i6.755
Abstract(886) |
Core Tip(830) |
Full Article(HTML)(6619)
|
Full Article with Cover (PDF)-4268K(143)
|
Full Article (Word)-1195K(39)
|
Audio-303K(10)
|
Peer-Review Report-179K(84)
|
Answering Reviewers-123K(68)
|
Full Article (PDF)-1940K(475)
|
Full Article (XML)-339K(85)
|
Times Cited (35)
|
Total Visits (11790)
|
Open
|
23 |
Ahmed Y. Sedeak, Marwa S. Abdel-Tawab, Naglaa A.A. Elazeem, Hoda R. Reyad, Sherif F. Abdel-Fatah, Yasser Khamis, Ahmed A.-E. Tammam, Ahmed M. El-Ebiary, Nourhan T. Sabra. The role of mesenchymal stem cell therapy in ameliorating diabetes-induced ovarian damage in albino rats: Histological, biochemical and immunohistochemical studies. Egyptian Pharmaceutical Journal 2024; 23(3): 407 doi: 10.4103/epj.epj_376_23
|
24 |
Ahmed Nabil, Koichiro Uto, Faten Zahran, Reham Soliman, Ayman A. Hassan, Mohamed M. Elshemy, Islam S. Ali, Mitsuhiro Ebara, Gamal Shiha, Vivekanand Vivekanand. The Potential Safe Antifibrotic Effect of Stem Cell Conditioned Medium and Nilotinib Combined Therapy by Selective Elimination of Rat Activated HSCs. BioMed Research International 2021; 2021(1) doi: 10.1155/2021/6678913
|
25 |
Sergei V. Jargin. Scientific Papers and Patents on Substances with Unproven Effects. Part 2. Recent Patents on Drug Delivery & Formulation 2020; 13(3): 160 doi: 10.2174/1872211313666190819124752
|
26 |
Ghulam Shere Raza, Nalini Sodum, Yagmur Kaya, Karl-Heinz Herzig. Role of Circadian Transcription Factor Rev-Erb in Metabolism and Tissue Fibrosis. International Journal of Molecular Sciences 2022; 23(21): 12954 doi: 10.3390/ijms232112954
|
27 |
Mahdi Masrour, Aysan Moeinafshar, Nima Rezaei. Comprehensive Hematology and Stem Cell Research. 2024; : 1 doi: 10.1016/B978-0-443-15717-2.00059-7
|
28 |
Chikkamenahalli Lakshminarayana Lakshmikanth, Shancy Petsel Jacob, Vyala Hanumanthareddy Chaithra, Hugo Caire de Castro-Faria-Neto, Gopal Kedihithlu Marathe. Sepsis: in search of cure. Inflammation Research 2016; 65(8): 587 doi: 10.1007/s00011-016-0937-y
|
29 |
Xia Li, Quan Jin, Yan-Ling Wu, Peng Sun, Shuang Jiang, Yu Zhang, De-Quan Zhang, Yu-Jing Zhang, Li-Hua Lian, Ji-Xing Nan. Tetrandrine regulates hepatic stellate cell activation via TAK1 and NF-κB signaling. International Immunopharmacology 2016; 36: 263 doi: 10.1016/j.intimp.2016.04.039
|
30 |
Lucija Virovic-Jukic, Dominik Ljubas, Sanja Stojsavljevic-Shapeski, Neven Ljubičić, Tajana Filipec Kanizaj, Ivana Mikolasevic, Ivica Grgurevic. Liver regeneration as treatment target for severe alcoholic hepatitis. World Journal of Gastroenterology 2022; 28(32): 4557-4573 doi: 10.3748/wjg.v28.i32.4557
|
31 |
Zhenxiong Ye, Wenfeng Lu, Lei Liang, Min Tang, Yunfeng Wang, Zhen Li, Heping Zeng, Aili Wang, Moubin Lin, Lei Huang, Hui Wang, Hai Hu. Mesenchymal stem cells overexpressing hepatocyte nuclear factor-4 alpha alleviate liver injury by modulating anti-inflammatory functions in mice. Stem Cell Research & Therapy 2019; 10(1) doi: 10.1186/s13287-019-1260-7
|
32 |
Samaneh Salehipour Bavarsad, Mohammad Taha Jalali, Darioush Bijan Nejad, Behnam Alypoor, Hossein Babaahmadi Rezaei, Narges Mohammadtaghvaei. TGFβ1-Pretreated Exosomes of Wharton Jelly Mesenchymal Stem Cell as a Therapeutic Strategy for Improving Liver Fibrosis. Hepatitis Monthly 2022; 22(1) doi: 10.5812/hepatmon-123416
|
33 |
Prakash Baligar, Snehasish Mukherjee, Veena Kochat, Archana Rastogi, Asok Mukhopadhyay. Molecular and Cellular Functions Distinguish Superior Therapeutic Efficiency of Bone Marrow CD45 Cells Over Mesenchymal Stem Cells in Liver Cirrhosis. Stem Cells 2016; 34(1): 135 doi: 10.1002/stem.2210
|
34 |
Sheeba Khan, Reenam S. Khan, Philip N. Newsome. Cell Therapy for Liver Disease: From Promise to Reality. Seminars in Liver Disease 2020; 40(04): 411 doi: 10.1055/s-0040-1717096
|
35 |
Mina Fathi-Kazerooni, Somaieh Kazemnejad, Sayeh Khanjani, Zohreh Saltanatpour, Gholamreza Tavoosidana. Down-regulation of miR-122 after transplantation of mesenchymal stem cells in acute liver failure in mice model. Biologicals 2019; 58: 64 doi: 10.1016/j.biologicals.2019.02.002
|
36 |
Huixing Liang, Ziming Wang, Junsong Wu, Xiang Li, D.T. Semirumi. Microstructural and micromechanical modeling of gum-gelatin-based soft tissue engineering scaffolds. International Journal of Biological Macromolecules 2023; 241: 124544 doi: 10.1016/j.ijbiomac.2023.124544
|
37 |
Mahdi Bahmani, Nasrin Ziamajidi, Mohammad Hashemnia, Roghayeh Abbasalipourkabir, Aref Salehzadeh. Human Umbilical Cord Blood Mesenchymal Stem Cell Conditioned Medium (hMSC-CM) Improves Antioxidant Status in Carbon Tetrachloride-Induced Oxidative Damage in Rat. Iranian Journal of Science and Technology, Transactions A: Science 2020; 44(5): 1327 doi: 10.1007/s40995-020-00944-x
|
38 |
Stephan Born, Max Johannes Dörfel, Philip Hartjen, Seyed Ali Haschemi Yekani, Julia Luecke, Juliane Katharina Meutsch, Julie Katharina Westphal, Moritz Birkelbach, Robert Köhnke, Ralf Smeets, Michael Krueger. A short-term plastic adherence incubation of the stromal vascular fraction leads to a predictable GMP-compliant cell-product. BioImpacts 2019; 9(3): 161 doi: 10.15171/bi.2019.20
|
39 |
Alvaro Moreira, Samuel Kahlenberg, Peter Hornsby. Therapeutic potential of mesenchymal stem cells for diabetes. Journal of Molecular Endocrinology 2017; 59(3): R109 doi: 10.1530/JME-17-0117
|
40 |
Zerui Wang, Tiantian Li, Ziying Zhang, Mengqi Yuan, Ming Shi, Fu-Sheng Wang, En-Qiang Linghu, Lei Shi. Human umbilical cord-derived mesenchymal stem cells for the treatment of decompensated cirrhosis (MSC-DLC-1): a dose-escalation, phase I trial protocol. BMJ Open 2023; 13(12): e078362 doi: 10.1136/bmjopen-2023-078362
|
41 |
Goshi Shiota, Noriko Itaba. Progress in stem cell‐based therapy for liver disease. Hepatology Research 2017; 47(2): 127 doi: 10.1111/hepr.12747
|
42 |
Marwa Abdelgwad, Manal Ewaiss, Dina Sabry, Warda A. Khalifa, Zeinab M. Altaib, Maha Alhelf. Comparative study on effect of mesenchymal stem cells and endothelial progenitor cells on treatment of experimental CCL4-induced liver fibrosis. Archives of Physiology and Biochemistry 2022; 128(4): 1071 doi: 10.1080/13813455.2020.1752256
|
43 |
P-Y Chang, Y-Q Qu, J Wang, L-H Dong. The potential of mesenchymal stem cells in the management of radiation enteropathy. Cell Death & Disease 2015; 6(8): e1840 doi: 10.1038/cddis.2015.189
|
44 |
Reju George Thomas, Afeesh Rajan Unnithan, Myeong Ju Moon, Suchithra Poilil Surendran, Tumurbaatar Batgerel, Chan Hee Park, Cheol Sang Kim, Yong Yeon Jeong. Electromagnetic manipulation enabled calcium alginate Janus microsphere for targeted delivery of mesenchymal stem cells. International Journal of Biological Macromolecules 2018; 110: 465 doi: 10.1016/j.ijbiomac.2018.01.003
|
45 |
Matthew E. Kinney, Robert Harman. Fowler's Zoo and Wild Animal Medicine Current Therapy, Volume 9. 2019; : 138 doi: 10.1016/B978-0-323-55228-8.00024-2
|
46 |
Chenxia Hu, Lingfei Zhao, Jingjing Tao, Lanjuan Li. Protective role of melatonin in early‐stage and end‐stage liver cirrhosis. Journal of Cellular and Molecular Medicine 2019; 23(11): 7151 doi: 10.1111/jcmm.14634
|
47 |
Qi Liu, Chengqian Lv, Yanan Jiang, Kunpeng Luo, Yang Gao, Jingyang Liu, Xu Zhang, Jan Mohammad Omar, Shizhu Jin. From hair to liver: emerging application of hair follicle mesenchymal stem cell transplantation reverses liver cirrhosis by blocking the TGF-β/Smad signaling pathway to inhibit pathological HSC activation. PeerJ 2022; 10: e12872 doi: 10.7717/peerj.12872
|
48 |
I.R. Al Delfi, J.J. Sheard, C.R. Wood, A. Vernallis, J.F. Innes, P. Myint, W.E.B. Johnson. Canine mesenchymal stem cells are neurotrophic and angiogenic: An in vitro assessment of their paracrine activity. The Veterinary Journal 2016; 217: 10 doi: 10.1016/j.tvjl.2016.09.003
|
49 |
Fernando Ezquer, Flavia Bruna, Sebastián Calligaris, Paulette Conget, Marcelo Ezquer. Multipotent mesenchymal stromal cells: A promising strategy to manage alcoholic liver disease. World Journal of Gastroenterology 2016; 22(1): 24-36 doi: 10.3748/wjg.v22.i1.24
|
50 |
Yang Guo, Bo Chen, Li-jun Chen, Chun-feng Zhang, Charlie Xiang. Current status and future prospects of mesenchymal stem cell therapy for liver fibrosis. Journal of Zhejiang University-SCIENCE B 2016; 17(11): 831 doi: 10.1631/jzus.B1600101
|
51 |
J Qiao. Occurrence, diagnosis and management of hepatic fibrosis and cirrhosis: An updated literature review. Archives of Hepatitis Research 2019; 5(1): 022 doi: 10.17352/ahr.000023
|
52 |
F. V. Hladkykh, I. V. Bielochkina, I. V. Koshurba, M. O. Chyzh. Modern hepatoprotection: a narrative review of existing approaches and prospects for the use of biotechnological drugs. Modern medical technology 2023; (3): 58 doi: 10.34287/MMT.3(58).2023.9
|
53 |
Min-Jeong Park, Misook Choi, Mina Kim, Don-Haeng Lee. Injectable and Cryopreservable MSC-Loaded PLGA Microspheres for Recovery from Chemically Induced Liver Damage. Macromolecular Research 2020; 28(11): 1017 doi: 10.1007/s13233-020-8139-4
|
54 |
Ola A. Gharib, Hanan A. Fahmy, Fatma Y. Abdou. Role of Olive Leaf Extract, Mesenchymal Stem Cells or Low Radiation Dose in Alleviating Hepatic Injury in Rats. Dose-Response 2024; 22(3) doi: 10.1177/15593258241289301
|
55 |
Nermin Raafat, Sara M. Abdel Aal, Fadia K. Abdo, Nabila M. El Ghonaimy. Mesenchymal stem cells: In vivo therapeutic application ameliorates carbon tetrachloride induced liver fibrosis in rats. The International Journal of Biochemistry & Cell Biology 2015; 68: 109 doi: 10.1016/j.biocel.2015.09.003
|
56 |
Yang Li, Jiantao Dong, Ye Zhou, Xueshuai Ye, Ziqi Cai, Xueqian Zhang, Li Shen, Mengya Zhang, Wanxing Zhang, Jianhui Cai. Therapeutic effects of CXCL9-overexpressing human umbilical cord mesenchymal stem cells on liver fibrosis in rats. Biochemical and Biophysical Research Communications 2021; 584: 87 doi: 10.1016/j.bbrc.2021.10.078
|
57 |
Nhung Hai Truong, Nam Hai Nguyen, Trinh Van Le, Huy Minh Le, Nghia Huynh, Dat Quoc Ngo, Thanh Van Nguyen, Ngoc Kim Phan, Phuc Van Pham. 6th International Conference on the Development of Biomedical Engineering in Vietnam (BME6). IFMBE Proceedings 2018; 63: 841 doi: 10.1007/978-981-10-4361-1_143
|
58 |
Nhung Hai Truong, Nam Hai Nguyen, Trinh Van Le, Ngoc Bich Vu, Nghia Huynh, Thanh Van Nguyen, Huy Minh Le, Ngoc Kim Phan, Phuc Van Pham, Shinn-Zong Lin. Comparison of the Treatment Efficiency of Bone Marrow‐Derived Mesenchymal Stem Cell Transplantation via Tail and Portal Veins in CCl4‐Induced Mouse Liver Fibrosis. Stem Cells International 2016; 2016(1) doi: 10.1155/2016/5720413
|
59 |
Sharmila Fagoonee, Elvira Smeralda Famulari, Lorenzo Silengo, Giovanni Camussi, Fiorella Altruda. Prospects for Adult Stem Cells in the Treatment of Liver Diseases. Stem Cells and Development 2016; 25(20): 1471 doi: 10.1089/scd.2016.0144
|
60 |
Kyeong-Ah Kwak, Hyun-Jae Cho, Jin-Young Yang, Young-Seok Park. Current Perspectives Regarding Stem Cell-Based Therapy for Liver Cirrhosis. Canadian Journal of Gastroenterology and Hepatology 2018; 2018: 1 doi: 10.1155/2018/4197857
|
61 |
Yan-Wei Li, Chong Zhang, Qiu-Ju Sheng, Han Bai, Yang Ding, Xiao-Guang Dou. Mesenchymal stem cells rescue acute hepatic failure by polarizing M2 macrophages. World Journal of Gastroenterology 2017; 23(45): 7978-7988 doi: 10.3748/wjg.v23.i45.7978
|
62 |
Ya Yang, Yalei Zhao, Lingjian Zhang, Fen Zhang, Lanjuan Li. The Application of Mesenchymal Stem Cells in the Treatment of Liver Diseases: Mechanism, Efficacy, and Safety Issues. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.655268
|
63 |
Bin Zhao, Yijie Zhang, Shichao Han, Wei Zhang, Qin Zhou, Hao Guan, Jiaqi Liu, Jihong Shi, Linlin Su, Dahai Hu. Exosomes derived from human amniotic epithelial cells accelerate wound healing and inhibit scar formation. Journal of Molecular Histology 2017; 48(2): 121 doi: 10.1007/s10735-017-9711-x
|
64 |
Samaneh Hosseini, Leila Taghiyar, Fatemeh Safari, Mohamadreza Baghaban Eslaminejad. Cell Biology and Translational Medicine, Volume 2. Advances in Experimental Medicine and Biology 2018; 1089: 115 doi: 10.1007/5584_2018_213
|
65 |
Apeksha Damania, Deepika Jaiman, Arun Kumar Teotia, Ashok Kumar. Mesenchymal stromal cell-derived exosome-rich fractionated secretome confers a hepatoprotective effect in liver injury. Stem Cell Research & Therapy 2018; 9(1) doi: 10.1186/s13287-017-0752-6
|
66 |
Luisa Vonghia, Mikhaïl A. Van Herck, Jonas Weyler, Sven Francque. Targeting Myeloid-Derived Cells: New Frontiers in the Treatment of Non-alcoholic and Alcoholic Liver Disease. Frontiers in Immunology 2019; 10 doi: 10.3389/fimmu.2019.00563
|
67 |
Yang Yang, Xiuhua Li, Wei Liu, Jingwen Chen, Changcheng Liu, Yongchao Cai, Yanxiang Song, Qinghe Tang, Chao Zhang, Zhiying He. Generation of Hepatocyte-Like Cells by Different Strategies for Liver Regeneration. Nano LIFE 2018; 8(04): 1841004 doi: 10.1142/S1793984418410040
|
68 |
Li-Ting Zhang, Xue-Bin Peng, Xue-Qin Fang, Jun-Feng Li, Hong Chen, Xiao-Rong Mao. Human umbilical cord mesenchymal stem cells inhibit proliferation of hepatic stellate cells in vitro. International Journal of Molecular Medicine 2018; doi: 10.3892/ijmm.2018.3500
|
69 |
Ruhma Mahmood, Mahmood Shaukat, Mahmood S Choudhery. Biological properties of mesenchymal stem cells derived from adipose tissue, umbilical cord tissue and bone marrow. AIMS Cell and Tissue Engineering 2018; 2(2): 78 doi: 10.3934/celltissue.2018.2.78
|
70 |
Lixing Xu, Jie Yang, Xinyu Cao, Jiayi Chen, Zhikuan Liu, Liangliang Cai, Yanyan Yu, Haiqin Huang. Sequential system based on ferritin delivery system and cell therapy for modulating the pathological microenvironment and promoting recovery. International Journal of Pharmaceutics 2024; 664: 124607 doi: 10.1016/j.ijpharm.2024.124607
|
71 |
Bruna Corradetti, Mauro Ferrari. Nanotechnology for mesenchymal stem cell therapies. Journal of Controlled Release 2016; 240: 242 doi: 10.1016/j.jconrel.2015.12.042
|
72 |
定伟 彭. Advances in Clinical Research and Application of Mesenchymal Stem Cells. Advances in Clinical Medicine 2022; 12(02): 1433 doi: 10.12677/ACM.2022.122208
|
73 |
Bruna Maria Manzini, Adriana da Silva Santos Duarte, Sundararaj Sankaramanivel, Aline Lisie Ramos, Paulo Latuf-Filho, Cecilia Escanhoela, Paulo Kharmandayan, Sara Teresinha Olalla Saad, Ilka Boin, Ângela Cristina Malheiros Luzo. Useful properties of undifferentiated mesenchymal stromal cells and adipose tissue as the source in liver-regenerative therapy studied in an animal model of severe acute fulminant hepatitis. Cytotherapy 2015; 17(8): 1052 doi: 10.1016/j.jcyt.2015.04.010
|
74 |
Maha M. Azzam, Abdelaziz M. Hussein, Basma H. Marghani, Nashwa M. Barakat, Mohsen M. M. Khedr, Nabil Abu Heakel. Retinoic Acid Potentiates the Therapeutic Efficiency of Bone Marrow-Derived Mesenchymal Stem Cells (BM-MSCs) against Cisplatin-Induced Hepatotoxicity in Rats. Scientia Pharmaceutica 2022; 90(4): 58 doi: 10.3390/scipharm90040058
|
75 |
James L. Funderburgh, Martha L. Funderburgh, Yiqin Du. Stem Cells in the Limbal Stroma. The Ocular Surface 2016; 14(2): 113 doi: 10.1016/j.jtos.2015.12.006
|
76 |
Mina Fathi-Kazerooni, Gholamreza Tavoosidana, Masoud Taghizadeh-Jahed, Sayeh Khanjani, Hananeh Golshahi, Caroline E. Gargett, Haleh Edalatkhah, Somaieh Kazemnejad. Comparative restoration of acute liver failure by menstrual blood stem cells compared with bone marrow stem cells in mice model. Cytotherapy 2017; 19(12): 1474 doi: 10.1016/j.jcyt.2017.08.022
|
77 |
Maria Teresa Borrello, Derek Mann. Chronic liver diseases: From development to novel pharmacological therapies: IUPHAR Review 37. British Journal of Pharmacology 2023; 180(22): 2880 doi: 10.1111/bph.15853
|
78 |
Shuji Terai, Atsunori Tsuchiya. Status of and candidates for cell therapy in liver cirrhosis: overcoming the “point of no return” in advanced liver cirrhosis. Journal of Gastroenterology 2017; 52(2): 129 doi: 10.1007/s00535-016-1258-1
|
79 |
Xia Yao, Jing Wang, Jiajing Zhu, Xiaoli Rong. The anti-fibrotic effect of human fetal skin-derived stem cell secretome on the liver fibrosis. Stem Cell Research & Therapy 2020; 11(1) doi: 10.1186/s13287-020-01891-5
|
80 |
Hamid Reza Ghasemi Basir, Ashkan Karbasi, Alireza Pouyandeh Ravan, Roghayeh Abbasalipourkabir, Mahdi Bahmani. Is human umbilical cord mesenchymal stem cell-derived conditioned medium effective against oxidative and inflammatory status in CCl4-induced acute liver injury?. Life Sciences 2022; 305: 120730 doi: 10.1016/j.lfs.2022.120730
|
81 |
In‐Su Park. Synergistic effect of three‐dimensional coculture and photobiomodulation therapy on vascularized liver spheroid formation by stem cells. Journal of Cellular Physiology 2021; 236(8): 5865 doi: 10.1002/jcp.30270
|
82 |
Masatsugu Ohara, Shunsuke Ohnishi, Hidetaka Hosono, Koji Yamamoto, Kohei Yuyama, Hideki Nakamura, Qingjie Fu, Osamu Maehara, Goki Suda, Naoya Sakamoto. Extracellular Vesicles from Amnion-Derived Mesenchymal Stem Cells Ameliorate Hepatic Inflammation and Fibrosis in Rats. Stem Cells International 2018; 2018: 1 doi: 10.1155/2018/3212643
|
83 |
Xuan Zhang, Ming-Gen Hu, Ke Pan, Chong-Hui Li, Rong Liu, Shimon Slavin. 3D Spheroid Culture Enhances the Expression of Antifibrotic Factors in Human Adipose‐Derived MSCs and Improves Their Therapeutic Effects on Hepatic Fibrosis. Stem Cells International 2016; 2016(1) doi: 10.1155/2016/4626073
|
84 |
Taufik Sungkar, Agung Putra, Dharma Lindarto, Rosita Juwita Sembiring. Anti-fibrotic effect of intravenous umbilical cord-derived mesenchymal stem cells (UC-MSCs) injection in experimental rats induced liver fibrosis. Medicinski Glasnik 2020; 18(1): 62 doi: 10.17392/1211-21
|
85 |
Mohammed R. Khalil, Reda S. El-Demerdash, Hazem H. Elminshawy, Eman T. Mehanna, Noha M. Mesbah, Dina M. Abo-Elmatty. Therapeutic effect of bone marrow mesenchymal stem cells in a rat model of carbon tetrachloride induced liver fibrosis. Biomedical Journal 2021; 44(5): 598 doi: 10.1016/j.bj.2020.04.011
|
86 |
Lijun Chen, Ning Zhang, Yuqi Huang, Qi Zhang, Yangxin Fang, Jiamin Fu, Yin Yuan, Lu Chen, Xin Chen, Zhenyu Xu, Yifei Li, Hiromi Izawa, Charlie Xiang. Multiple Dimensions of using Mesenchymal Stem Cells for Treating Liver Diseases: From Bench to Beside. Stem Cell Reviews and Reports 2023; 19(7): 2192 doi: 10.1007/s12015-023-10583-5
|
87 |
Nageh Ahmed Elmahdy, Samia Salem Sokar, Mohamed Labib Salem, Naglaa Ibrahim Sarhan, Sherin Hamed Abou-Elela. Anti-fibrotic potential of human umbilical cord mononuclear cells and mouse bone marrow cells in CCl4- induced liver fibrosis in mice. Biomedicine & Pharmacotherapy 2017; 89: 1378 doi: 10.1016/j.biopha.2017.03.007
|
88 |
O. V. Payushina, D. A. Tsomartova, Y. V. Chereshneva, M. Yu. Ivanova, S. L. Kuznetsov. Regulatory Effect of Mesenchymal Stromal Cells on the Development of Liver Fibrosis: Cellular and Molecular Mechanisms and Prospects for Clinical Application. Biology Bulletin Reviews 2021; 11(1): 54 doi: 10.1134/S2079086421010059
|
89 |
Lei Lian, Qunsheng Huang, Longjuan Zhang, Huabo Qin, Xiaosheng He, Xin He, Jia Ke, Minghao Xie, Ping Lan. Anti-fibrogenic Potential of Mesenchymal Stromal Cells in Treating Fibrosis in Crohn’s Disease. Digestive Diseases and Sciences 2018; 63(7): 1821 doi: 10.1007/s10620-018-5082-8
|
90 |
Chien-Wei Lee, Yu-Fan Chen, Hao-Hsiang Wu, Oscar K. Lee. Historical Perspectives and Advances in Mesenchymal Stem Cell Research for the Treatment of Liver Diseases. Gastroenterology 2018; 154(1): 46 doi: 10.1053/j.gastro.2017.09.049
|
91 |
Ji Xuan, Wang Feng, Zheng-tao An, Jian Yang, Hua-bing Xu, Jing Li, Zhi-fei Zhao, Wei Wen. Anti-TGFβ-1 receptor inhibitor mediates the efficacy of the human umbilical cord mesenchymal stem cells against liver fibrosis through TGFβ-1/Smad pathway. Molecular and Cellular Biochemistry 2017; 429(1-2): 113 doi: 10.1007/s11010-017-2940-1
|
92 |
Esteban J. Fiore, Guillermo Mazzolini, Jorge B. Aquino. Mesenchymal Stem/Stromal Cells in Liver Fibrosis: Recent Findings, Old/New Caveats and Future Perspectives. Stem Cell Reviews and Reports 2015; 11(4): 586 doi: 10.1007/s12015-015-9585-9
|
93 |
Ezra Endria Gunadi, Yan Wisnu Prajoko, Agung Putra. Effectiveness of Mesenchymal Stem Cells and Bovine Colostrum on Decreasing Tumor Necrosis Factor-Α Levels and Enhancement of Macrophages M2 in Remnant Liver. Open Access Macedonian Journal of Medical Sciences 2021; 9(A): 1195 doi: 10.3889/oamjms.2021.7902
|
94 |
Simone Gabner, Juraj Hlavaty, Karsten Velde, Matthias Renner, Florien Jenner, Monika Egerbacher. Inflammation‐induced transgene expression in genetically engineered equine mesenchymal stem cells. The Journal of Gene Medicine 2016; 18(8): 154 doi: 10.1002/jgm.2888
|
95 |
Jieun Kim, Chanbin Lee, Yongbo Shin, Sihyung Wang, Jinsol Han, Minju Kim, Ji Min Kim, Sung-Chan Shin, Byung-Joo Lee, Tae-Jin Kim, Youngmi Jung. sEVs from tonsil-derived mesenchymal stromal cells alleviate activation of hepatic stellate cells and liver fibrosis through miR-486-5p. Molecular Therapy 2021; 29(4): 1471 doi: 10.1016/j.ymthe.2020.12.025
|
96 |
Tahereh Rostami, Nasrollah Maleki, Amir Kasaeian, Mohsen Nikbakht, Azadeh Kiumarsi, Seyed Asadollah Mousavi, Ardeshir Ghavamzadeh. Co‐transplantation of bone marrow‐derived mesenchymal stem cells with hematopoietic stem cells does not improve transplantation outcome in class III beta‐thalassemia major: A prospective cohort study with long‐term follow‐up. Pediatric Transplantation 2021; 25(3) doi: 10.1111/petr.13905
|
97 |
Ying Han, Lanzhu Yue, Max Wei, Xiubao Ren, Zonghong Shao, Ling Zhang, Ross L. Levine, Pearlie K. Epling-Burnette, Connie J. Eaves. Mesenchymal Cell Reprogramming in Experimental MPLW515L Mouse Model of Myelofibrosis. PLOS ONE 2017; 12(1): e0166014 doi: 10.1371/journal.pone.0166014
|
98 |
Pilar Sainz-Arnal, Iris Pla-Palacín, Natalia Sánchez-Romero, Manuel Almeida, Sara Morini, Estela Solanas, Alberto Lue, Trinidad Serrano-Aulló, Pedro M. Baptista. Principles of Regenerative Medicine. 2019; : 1101 doi: 10.1016/B978-0-12-809880-6.00062-X
|
99 |
Wenyi Chen, Feiyan Lin, Xudong Feng, Qigu Yao, Yingduo Yu, Feiqiong Gao, Jiahang Zhou, Qiaoling Pan, Jian Wu, Jinfeng Yang, Jiong Yu, Hongcui Cao, Lanjuan Li. MSC-derived exosomes attenuate hepatic fibrosis in primary sclerosing cholangitis through inhibition of Th17 differentiation. Asian Journal of Pharmaceutical Sciences 2024; 19(1): 100889 doi: 10.1016/j.ajps.2024.100889
|
100 |
Minyeoung Kweon, Jae Yeon Kim, Ji Hye Jun, Gi Jin Kim. Research Trends in the Efficacy of Stem Cell Therapy for Hepatic Diseases Based on MicroRNA Profiling. International Journal of Molecular Sciences 2020; 22(1): 239 doi: 10.3390/ijms22010239
|
101 |
Meixian Jin, Xiao Yi, Xiaojuan Zhu, Wei Hu, Simin Wang, Qi Chen, Wanren Yang, Yang Li, Shao Li, Qing Peng, Mingxin Pan, Yi Gao, Shiyuan Xu, Ying Zhang, Shuqin Zhou. Schisandrin B promotes hepatic differentiation from human umbilical cord mesenchymal stem cells. iScience 2024; 27(2): 108912 doi: 10.1016/j.isci.2024.108912
|